Here’s a roundup of the latest coronavirus-related news.
The number of coronavirus disease 2019 (COVID-19) cases in the United States continue to surge, with a weekly average of 266,000 daily cases and an estimated 132,000 COVID-19––related hospitalizations as of January 7, according to The COVID Tracking Project.
Here’s a roundup of the latest coronavirus-related news:
In a briefing on Wednesday, Infectious Diseases Society of America (IDSA) board of directors members discussed revised recommendations for COVID-19 diagnostic testing.
Moderna is increasing the estimated number of doses of its COVID-19 vaccine that it expects to produce to 600 million for 2021, according to a company statement.
Officials with the FDA took a stance on the authorized dosing schedules for COVID-19 vaccines, stating that all health care professionals should continue to administer 2 full doses of the vaccine, according to a statement.
Biotechnology company Novavax has announced the start of its phase 3 study evaluating a vaccine candidate for COVID-19.
In this final part of a 3-part video series, Craig Samitt, CEO and president of Blue Cross Blue Shield of Minnesota talks with Managed Healthcare Executive about their focus on social determinants of health and the COVID-19 vaccine.